Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Juan Luis Chico García"'
Autor:
Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, Juan Luis Chico García, José Ignacio Fernández Velasco, Noelia Villarrubia, Jose Luis Veiga González, Susana Sainz de la Maza, Fernando Rodríguez Jorge, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAlemtuzumab is a highly effective pulsed immune reconstitution therapy for multiple sclerosis (MS).AimTo evaluate serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) in patients with relapsing-remittin
Externí odkaz:
https://doaj.org/article/dd92d345eae2484390381b8e9f58bd9e
Autor:
Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Vaccines, Vol 11, Iss 9, p 1399 (2023)
This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain. Blood samples were collected o
Externí odkaz:
https://doaj.org/article/4d8709038bee489ea32a0e871e762155
Autor:
Susana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, Enric Monreal, Alexander Rodero-Romero, Juan Luis Chico-García, Roberto Pariente, Fernando Rodríguez-Jorge, Rubén Ballester-González, Noelia Villarrubia, Beatriz Romero-Hernández, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Publikováno v:
Vaccines, Vol 11, Iss 4, p 786 (2023)
Background: This study aimed to evaluate short- and long-term humoral and T-cell-specific immune responses to SARS-CoV-2 vaccines in patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). Methods: Single-cent
Externí odkaz:
https://doaj.org/article/e47df56766a24d768e19edea261665bc
Autor:
Victoria Ros-Castelló, Elena Natera-Villalba, Ana Gómez-López, Arantxa Sánchez-Sánchez, Juan Luis Chico-García, Sebastian García-Madrona, Rocio Vera-Lechuga, Consuelo Matute-Lozano, Alicia de Felipe Mimbrera, Antonio Cruz-Culebras, Araceli Alonso-Canovas, Jaime Masjuan
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 166-173 (2020)
Background: The use of the cardiovascular polypill, a fixed-dose combination treatment, is conceived to improve adherence. However, randomized controlled trials (RCTs) may overestimate it. Studies focusing on cerebrovascular disease and real-life eff
Externí odkaz:
https://doaj.org/article/e53870cc2572474fa90413565c42d569
Autor:
Juan Luis Chico-García, Fernando Rodríguez-Jorge, Raquel Sainz-Amo, Enric Monreal, Paulette Walo-Delgado, Ernesto Roldán, Eulalia Rodríguez-Martín, Jaime Masjuan, Lucienne Costa-Frossard, Susana Sainz de la Maza, Luisa Maria Villar
Publikováno v:
Multiple sclerosis and related disorders. 68
Rituximab is extensively used for multiple sclerosis (MS) treatment. However, the best dosage remains to be established. It has been proposed that retreatment could be guided by B lymphocyte (BL) percentages.To establish the best BL value for retreat
Autor:
Clara Lastras Fernandez-Escandon, Juan Luis Chico-García, Paloma Parra-Díaz, Fernando Rodríguez-Jorge, Juan Carlos Martínez-Castrillo, Araceli Alonso-Canovas, Álvaro Beltrán-Corbellini
Publikováno v:
Mov Disord Clin Pract
BACKGROUND: Impulse control disorders (ICDs) have an increased frequency in patients with Parkinson's disease (PD), mainly because of treatment with dopamine agonists (DA). Factors related with the country of origin (culture, economy, healthcare poli
Autor:
Andrés, Labiano-Fontcuberta, Lucienne, Costa-Frossard, Susana, Sainz de la Maza, Fernando, Rodríguez-Jorge, Juan Luis, Chico-García, Enric, Monreal
Publikováno v:
Multiple Sclerosis and Related Disorders. 64:103959
The potential influence of the timing of high-efficacy disease-modifying therapies (heDMTs) on processing speed (PS) performance is critically lacking in current literature.To assess the extent to which early commencement of heDMTs would be associate
Autor:
Enric Monreal, Susana Sainz de la Maza, Pedro Gullón, Elena Natera-Villalba, Juan Luis Chico-García, Álvaro Beltrán-Corbellini, Javier Martínez-Sanz, Nuria García-Barragán, Javier Buisán, Rafael Toledano, Araceli Alonso-Canovas, Paula Pérez-Torre, María Consuelo Matute-Lozano, Jose Luis López-Sendón, Guillermo García-Ribas, Íñigo Corral, Jesús Fortún, Beatriz Montero-Errasquín, Luis Manzano, Luis Máiz-Carro, Lucienne Costa-Frossard, Jaime Masjuan
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that has spread rapidly worldwide. The role of immunosuppression among COVID-19 patients has not been elucidated and management may be challenging. OBJECTIVE: To assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54681e66fe00a3d86b194907a6fa4cdb
https://doi.org/10.21203/rs.3.rs-27095/v2
https://doi.org/10.21203/rs.3.rs-27095/v2
Autor:
Nuria García-Barragán, Pedro Gullón, Javier Martínez-Sanz, Enric Monreal, Juan Luis Chico-García, Araceli Alonso-Canovas, Jaime Masjuan, Lucienne Costa-Frossard, Jesús Fortún, Paula Pérez-Torre, J.L. López-Sendón, Javier Buisán, Elena Natera-Villalba, Luis Máiz-Carro, Sainz de la Maza S, Álvaro Beltrán-Corbellini, Beatriz Montero-Errasquín, Rafael Toledano, Iñigo Corral, Guillermo García-Ribas, Luis Manzano, María Consuelo Matute-Lozano
Publikováno v:
Journal of Medical Virology
The role of immunosuppression among coronavirus disease 2019 (COVID-19) patients has not been elucidated and management may be challenging. This observational study included confirmed COVID-19 patients. The primary endpoint was the development of mod
Autor:
Jaime Masjuan, Sebastián García-Madrona, Rocio Vera-Lechuga, Alicia DeFelipe-Mimbrera, Juan Luis Chico-García, Consuelo Matute-Lozano, Fernando Rodríguez-Jorge, Álvaro Beltrán-Corbellini, Ana Pardo-Sanz, A. Cruz-Culebras, Paloma Parra-Díaz, Luisa Salido-Tahoces
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 30(3)
Introduction In previous studies the risk of stroke recurrence has been associated with the left atrial appendage (LAA) morphology (non-chicken wing (NCW)), knowing those with a greater risk as malignant LAA. Recently, a simpler morphological classif